Frank Camma analyst

Currently out of the existing stock ratings of Frank Camma, 20 are a BUY (45.45%), 24 are a HOLD (54.55%).

Frank Camma

Work Performance Price Targets & Ratings Chart

Analyst Frank Camma, carries an average stock price target met ratio of 69.44% that have a potential upside of 41.84% achieved within 688 days. Previously, Frank Camma worked at SIDOTI.

Frank Camma’s has documented 84 price targets and ratings displayed on 13 stocks. The coverage was on Consumer Defensive, Consumer Cyclical, Industrials, Healthcare sectors.

Most recent stock forecast was given on PBH, Prestige Brand Holdings at 24-Sep-2025.

Wall Street Analyst Frank Camma

Analyst best performing recommendations are on MED (MEDIFAST INC).
The best stock recommendation documented was for TREX (TREX COMPANY) at 8/6/2019. The price target of $42 was fulfilled within 7 days with a profit of $1.5 (3.7%) receiving and performance score of 5.29.

Average potential price target upside

HELE Helen of Troy Ltd IRBT iRobot MED MEDIFAST INC TREX Trex Company WTW Willis Towers Watson PLC MOV Movado Group WW WW International CENTA Central Garden & Pet Company A LCUT Lifetime Brands LANC Lancaster Colony RICK RCI Hospitality Holdings IR Ingersoll Rand PBH Prestige Brand Holdings

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 17-Apr-2023

$25

$-3.38 (-11.91%)

$16

2 months 14 days ago
(24-Apr-2026)

11/18 (61.11%)

$1.38 (5.84%)

82

Hold Since 10-Oct-2025

$23

$-5.38 (-18.96%)

2 months 14 days ago
(24-Apr-2026)

3/3 (100%)

$-0.62 (-2.62%)

107

Hold Since 10-Oct-2024

$78

$49.62 (174.84%)

$71

1 years 7 months 13 days ago
(25-Nov-2024)

26/36 (72.22%)

$6.33 (8.83%)

127

Hold Since 13-Jul-2022

$235

3 years 11 months 25 days ago
(13-Jul-2022)

5/5 (100%)

$20.9 (9.76%)

70

Buy Since 12-Sep-2017

$206

$189.27 (1131.32%)

$206

4 years 1 days ago
(07-Jul-2022)

3/5 (60%)

$51.25 (33.12%)

132

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Frank Camma?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?